Investor Relations

Company Overview

Conversion Labs (OTCQB: CVLB) is a direct response, e-commerce company with a portfolio of brands. CVLB leverages a proprietary, highly scalable and global advertising technology platform powered by Facebook, Google and Amazon, the world’s largest online advertising platforms. Conversion Labs’ lead brand is Shapiro MD, a patented, dermatologist-developed hair loss treatment system that has been purchased by more than 200,000 people around the world within the first 24 months of launch. Conversion Labs actively seeks to acquire, develop and launch innovative brands in the technology and wellness sectors.

In June 2018, CVLB acquired 51% of PDF Simpli, a direct response software as a service (SaaS) business that enables users to convert, edit and sign PDF documents. Since acquisition, PDF Simpli has grown from approximately 10,000 registrants to over 1 million, and is presently ranked in the top 50,000 websites globally and markets to over 100 countries around the world.

In June 2019, Conversion Labs announced a telemedicine-focused joint venture and strategic partnership with GoGoMeds. GoGoMeds is a large online pharmacy licensed to dispense and ship prescription drugs to patients in all 50 states and the District of Columbia. Conversion Labs intends to leverage this partnership to offer prescription drugs in tandem with existing product lines in addition to launching several new ‘branded generic’ drug offers that will be marketed directly to consumers in the United States.

Stock Information






52 week Low/High

Day Low/High

Latest 10-K

View Latest 10-K


Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Conversion Labs, Inc.
800 Third Avenue
Suite 2800
New York, NY 10022

Investor Relations

T: 866-351-5907 Ext: 5

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601